Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intact Genomics is a private biotechnology company based in St. Louis, Missouri that develops and sells molecular biology reagents, competent cells, amplification kits, cloning products, and custom genomic services for research and diagnostic applications. The company focuses on isothermal DNA/RNA amplification, gene editing, simplified molecular cloning, protein expression, and large DNA fragment capture and cloning. It also promotes proprietary platform technologies including Fungal Artificial Chromosome (FAC) and 100kb Large DNA Fragment methods to enable natural product discovery and metagenomics research. In addition to catalog products, Intact Genomics provides custom services such as BAC and fosmid library work, DNA preparation, screening, and related genomic support. The company appears to be primarily a commercial life science tools and services business rather than a therapeutic drug developer, although it also markets igTherapeutics pharmaceutical R&D services around natural product discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intact Genomics.